Logo Image
NP/PA Connect
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference ListingNP/PA Conferences
Events
NP/PA EventsCase-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
Awareness SpotlightInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Watch
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Anti-Aging
  • Artificial Intelligence
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hair & Scalp
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Spotlight -
NP/PA Connect|
Acne|
Atopic Dermatitis|
Chronic Hand Eczema|
Chronic Spontaneous Urticaria|
Drug Watch|
Hidradenitis Suppurativa|
Psoriasis|
Skin Cancer|
Vitiligo
Advertisement

Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

Advertisement

Articles by Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

ByApril W. Armstrong, MD, MPH, Professor and Chief of Dermatology​, University of California, Los Angeles​,Kassim Rahawi, PharmD, Sanofi, Cambridge, USA,Wendell Valdecantos, MD, Sanofi, Cambridge, USA,Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA
October 22nd 2024

Sponsored Content

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

Advertisement

Latest Updated Articles

  • OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?
    OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

    October 22nd 2024



Advertisement
Advertisement

Trending on Dermatology Times

1

Updated HS Guidelines Emphasize Biologics and Early Intervention

2

Dermatology Times Monthly FDA and Pipeline Review: October 2026

3

Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year

4

Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients

5

PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us